CAS 117977-21-6
:Rabeprazol-tioéter
Descripción:
Rabeprazol-tioéter es un derivado del rabeprazol, un inhibidor de la bomba de protones comúnmente utilizado para tratar condiciones como la enfermedad por reflujo gastroesofágico (ERGE) y las úlceras pépticas. Este compuesto presenta un grupo funcional tioéter, que puede influir en sus propiedades farmacológicas, incluida la solubilidad y la estabilidad metabólica. El rabeprazol en sí es conocido por su capacidad para inhibir la enzima H+/K+ ATPasa en las células parietales gástricas, reduciendo así la secreción de ácido gástrico. La modificación tioéter puede mejorar su biodisponibilidad o alterar su interacción con los objetivos biológicos. Típicamente, compuestos como Rabeprazol-tioéter se caracterizan por su peso molecular, fórmula estructural y grupos funcionales específicos, que contribuyen a su reactividad química y eficacia terapéutica. Además, la estabilidad del compuesto, la solubilidad en varios disolventes y los posibles efectos secundarios son características importantes que a menudo se evalúan durante el desarrollo de medicamentos y el uso clínico. En general, Rabeprazol-tioéter representa una modificación destinada a optimizar los efectos terapéuticos del rabeprazol mientras se minimizan potencialmente los efectos adversos.
Fórmula:C18H21N3O2S
InChI:InChI=1S/C18H21N3O2S/c1-13-16(19-9-8-17(13)23-11-5-10-22-2)12-24-18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)
Clave InChI:InChIKey=BSXAHDOWMOSVAP-UHFFFAOYSA-N
SMILES:S(CC1=C(C)C(OCCCOC)=CC=N1)C=2NC=3C(N2)=CC=CC3
Sinónimos:- 1H-Benzimidazole,2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-
- 2-(((4-(3-Methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
- 2-[((4-(3-Methoxypropoxy)-3-methylpyridine-2-yl)methyl)thio]-1H-benzimidazole
- 2-[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H-benzimidazole
- 2-[[[3-Methyl-4-(3-methoxypropoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole
- 2-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
- 2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole
- H 295/43
- Rabeprazole-thioether
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Encontrado 13 productos.
Rabeprazole Sulfide
CAS:Fórmula:C18H21N3O2SPureza:>98.0%(T)(HPLC)Forma y color:White to Almost white powder to crystalPeso molecular:343.45Rabeprazole Related Compound E (2-{[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methylthio}benzimidazole)
CAS:Aromatic or modified aromatic heterocyclic compounds wiFórmula:C18H21N3O2SForma y color:White Off-White PowderPeso molecular:343.135452-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole
CAS:Fórmula:C18H21N3O2SPureza:98%Forma y color:SolidPeso molecular:343.44322-{[4-(3-Methoxypropoxy)-3-Methylpyridine-2-yl]Methylthio}-1H-Benzimidazole
CAS:2-{[4-(3-Methoxypropoxy)-3-Methylpyridine-2-yl]Methylthio}-1H-BenzimidazolePureza:98%Peso molecular:343.44g/molRabeprazole EP Impurity B (Rabeprazole Sulfide)
CAS:Fórmula:C18H21N3O2SForma y color:White To Off-White SolidPeso molecular:343.452-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
CAS:Producto controladoForma y color:NeatRabeprazole Sulfide
CAS:Rabeprazole Sulfide (Rabeprazole Related Compound E) is an antiulcer drug in the class of proton pump inhibitors.Fórmula:C18H21N3O2SPureza:99.34% - 99.78%Forma y color:Off-White Crystalline PowderPeso molecular:343.44Rabeprazole Sulfide
CAS:<p>Impurity Rabeprazole EP Impurity B<br>Applications Rabeprazole Sulfide (Rabeprazole EP Impurity B) is a metabolite of Rabeprazole (R070500).<br>References Yoshida, T., et al.: Biotech. Lett., 23, 1217 (2001), Miura, M., et al.: Eur. J. Clin. Pharmacol., 62, 113 (2006), Sheridan, R.P., et al.: J. Med. Chem., 50, 3173 (2007), Ren, S., et al.: Arc. Pharm. Res., 31, 406 (2008),<br></p>Fórmula:C18H21N3O2SForma y color:NeatPeso molecular:343.452-[[[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl ]methyl]thio]-1H-benzimidazole
CAS:Pureza:95.0%Forma y color:SolidPeso molecular:343.450012207031252-[[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methyl]thio]-1H-benzimidazole
CAS:<p>Rabeprazole is a proton pump inhibitor that is used to treat acid-related disorders such as gastroesophageal reflux disease and peptic ulcers. Rabeprazole inhibits the production of gastric acid by blocking the hydrogen/potassium ATPase that is found in the parietal cells of the stomach. The main mechanism of action for rabeprazole is competitive inhibition of the proton pump, which leads to decreased gastric acid secretion. Rabeprazole can be administered orally or intravenously, with a half-life of about 2 hours. It has been shown to have an effect on human liver cytochrome P450s, but does not affect the activity of recombinant cytochrome P450 3A4 (CYP3A4). In clinical studies, rabeprazole was shown to have no adverse effects on CYP3A4 activity and may even increase it slightly.</p>Fórmula:C18H21N3O2SPureza:Min. 95%Forma y color:White PowderPeso molecular:343.44 g/molRabeprazole-D4 Sulfide
CAS:Producto controlado<p>Applications Rabeprazole-D4 Sulfide is an intermediate in the synthesis of Rabeprazole-d4 (R070492). Rabeprazole-D4 Sulfide is an isotope-labeled analogue of Rabeprazole Sulfide (Rabeprazole EP Impurity B), which is a metabolite of Rabeprazole (R070500).<br>References Morii, M., and Takeguchi, N.: J. Biol. Chem., 268, 21553 (1993); Yasuda, S., et al.: Int. J. Clin. Pharmacol. Ther., 32, 466 (1994); Cloud, M.L., et al.: Dig. Dis. Sci., 43, 993 (1998)<br></p>Fórmula:C18D4H17N3O2SForma y color:NeatPeso molecular:347.468











